Search research articles
Contact Us
Filters
Showing results (41-50 of 67) with videos related to
Page
of 7
Sort By:
Clinical Ophthalmology (Auckland, N.Z.)
|
July 2, 2013
Automated grading system for evaluation of ocular redness associated with dry eye
John D Rodriguez, Patrick R Johnston, George W Ousler, et al.
American Journal of Ophthalmology
|
April 1, 2008
Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial
Mark B Abelson, Warren Heller, Aron M Shapiro, et al.
Journal of Asthma and Allergy
|
March 19, 2019
Iodixanol nasal solution reduces allergic rhinoconjunctivitis signs and symptoms in Allergen BioCube<sup>®</sup>: a randomized clinical trial
Paul J Gomes, Mark B Abelson, Linda Stein, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
January 11, 2017
Vehicle-Controlled, Phase 2 Clinical Trial of a Sustained-Release Dexamethasone Intracanalicular Insert in a Chronic Allergen Challenge Model
Gail Torkildsen, Mark B Abelson, Paul J Gomes, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
May 17, 2014
Blink patterns and lid-contact times in dry-eye and normal subjects
George W Ousler, Mark B Abelson, Patrick R Johnston, et al.
Investigative Ophthalmology & Visual Science
|
June 13, 2015
Automated Grading System for Evaluation of Superficial Punctate Keratitis Associated With Dry Eye
John D Rodriguez, Keith J Lane, George W Ousler, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
August 12, 2024
Advantages of Lissamine Green Vital Staining as an Endpoint in Dry Eye Clinical Trials
John D Rodriguez, Samantha Kerti, Adam Hamm, et al.
Current Eye Research
|
October 19, 2017
Blink: Characteristics, Controls, and Relation to Dry Eyes
John D Rodriguez, Keith J Lane, George W Ousler, et al.
Allergy and Asthma Proceedings
|
September 22, 2007
Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis
Mark B Abelson, Paul J Gomes, Terri Pasquine, et al.
Clinical Therapeutics
|
March 5, 2004
Efficacy and tolerability of ophthalmic epinastine assessed using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitis
Mark B Abelson, Paul Gomes, H Jerome Crampton, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 67) with videos related to
Sort By:
Page
of 7
Clinical Ophthalmology (Auckland, N.Z.)
|
July 2, 2013
Automated grading system for evaluation of ocular redness associated with dry eye
John D Rodriguez, Patrick R Johnston, George W Ousler, et al.
American Journal of Ophthalmology
|
April 1, 2008
Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial
Mark B Abelson, Warren Heller, Aron M Shapiro, et al.
Journal of Asthma and Allergy
|
March 19, 2019
Iodixanol nasal solution reduces allergic rhinoconjunctivitis signs and symptoms in Allergen BioCube<sup>®</sup>: a randomized clinical trial
Paul J Gomes, Mark B Abelson, Linda Stein, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
January 11, 2017
Vehicle-Controlled, Phase 2 Clinical Trial of a Sustained-Release Dexamethasone Intracanalicular Insert in a Chronic Allergen Challenge Model
Gail Torkildsen, Mark B Abelson, Paul J Gomes, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
May 17, 2014
Blink patterns and lid-contact times in dry-eye and normal subjects
George W Ousler, Mark B Abelson, Patrick R Johnston, et al.
Investigative Ophthalmology & Visual Science
|
June 13, 2015
Automated Grading System for Evaluation of Superficial Punctate Keratitis Associated With Dry Eye
John D Rodriguez, Keith J Lane, George W Ousler, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
August 12, 2024
Advantages of Lissamine Green Vital Staining as an Endpoint in Dry Eye Clinical Trials
John D Rodriguez, Samantha Kerti, Adam Hamm, et al.
Current Eye Research
|
October 19, 2017
Blink: Characteristics, Controls, and Relation to Dry Eyes
John D Rodriguez, Keith J Lane, George W Ousler, et al.
Allergy and Asthma Proceedings
|
September 22, 2007
Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis
Mark B Abelson, Paul J Gomes, Terri Pasquine, et al.
Clinical Therapeutics
|
March 5, 2004
Efficacy and tolerability of ophthalmic epinastine assessed using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitis
Mark B Abelson, Paul Gomes, H Jerome Crampton, et al.
Page
of 7